This book offers an in-depth exploration of the latest advances in cancer therapeutics, with a strong focus on innovative drug strategies and molecular breakthroughs that are shaping the future of oncology. It explores a broad range of modern treatment approaches, including immunotherapy, targeted therapies, epigenetic modulators, and next-generation drug delivery systems.The chapters explore a wide range of topics including small molecule inhibitors, monoclonal antibodies, nanotechnology-based interventions, and emerging tools like CRISPR and AI-driven drug discovery. A key strength of the book is its integration of scientific innovation with clinical translation and regulatory considerations, offering both depth and practical relevance.By bridging the gap between research and real-world application, this book provides a forward-looking roadmap for the future of cancer care. It is an essential resource for oncologists, biomedical researchers, pharmaceutical professionals, and post-graduate students seeking a clear and up-to-date understanding of current and next-generation cancer treatments.